Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases

Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases

Liver sinusoidal endothelial cells have a gatekeeper function in liver homeostasis by permitting substrates from the bloodstream into the space of Disse and regulating hepatic stellate cell activation status. Maintenance of LSEC's highly specialized phenotype is crucial for liver homeostasis. D...

Full description

Bibliographic Details
Main Authors:	Stefaan Verhulst, Elise Anne van Os, Vincent De Smet, Nathalie Eysackers, Inge Mannaerts, Leo A. van Grunsven
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Medicine
Subjects:	LSEC acute liver injury single cell RNA sequencing (scRNAseq) primary cells NAFLD (non-alcoholic fatty liver disease) non-alcoholic steatohepatitis (NASH)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.750044/full

Similar Items

LSEC Fenestrae Are Preserved Despite Pro-inflammatory Phenotype of Liver Sinusoidal Endothelial Cells in Mice on High Fat Diet
by: Edyta Kus, et al.
Published: (2019-02-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
by: Yan Huang, et al.
Published: (2022-01-01)

Single-cell transcriptome reveals a novel mechanism of C-Kit+-liver sinusoidal endothelial cells in NASH
by: Hui-Yi Li, et al.
Published: (2024-03-01)

Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)

Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease
by: HAO Dandan, ZHANG Lei, BAI Chunying
Published: (2023-08-01)

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
by: Oliver Krenkel, et al.
Published: (2019-05-01)

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
by: Christina-Maria Flessa, et al.
Published: (2022-12-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma
by: Etienne Delangre, et al.
Published: (2022-09-01)

The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis
by: Stamatina Vogli, et al.
Published: (2023-08-01)

Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles
by: Stefaan Verhulst, et al.
Published: (2019-09-01)

Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Nelson Kei, et al.
Published: (2023-09-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
by: Christoph Roderburg, et al.
Published: (2023-04-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
by: Nicha Wongjarupong, et al.
Published: (2017-12-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
by: Sukrit Kanchanasurakit, et al.
Published: (2022-05-01)

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
by: Rodrigo Zamignan Carpi, et al.
Published: (2022-08-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
by: Yang Xiao, et al.
Published: (2021-08-01)

Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis
by: Shui-Xian Du, et al.
Published: (2017-12-01)

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
by: Deniz Tümen, et al.
Published: (2022-12-01)

Preventative and Therapeutic Effects of Astaxanthin on NAFLD
by: Nor Hafiza Sayuti, et al.
Published: (2023-08-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
by: Alessandro Mantovani, et al.
Published: (2022-02-01)

Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
by: Maite Martínez-Uña, et al.
Published: (2020-12-01)

SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites
by: Xingyu Li, et al.
Published: (2023-05-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice
by: Maria Guarino, et al.
Published: (2020-05-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
by: Constanze Hoebinger, et al.
Published: (2022-01-01)

Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?
by: Mi-Young Kim, et al.
Published: (2020-12-01)

Involvement of a periodontal pathogen, <it>Porphyromonas gingivalis </it>on the pathogenesis of non-alcoholic fatty liver disease
by: Yoneda Masato, et al.
Published: (2012-02-01)

Loss of hepatic VMP1 trapped VLDL in the bilayer of endoplasmic reticulum membrane
by: Hong-Min Ni, et al.
Published: (2023-06-01)

Vitamins and non-alcoholic fatty liver disease: A molecular insight
by: Sana Raza, et al.
Published: (2021-06-01)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
by: Ana Sandoval-Rodriguez, et al.
Published: (2022-04-01)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
by: Laura Valenzuela-Vallejo, et al.
Published: (2023-05-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)